Cargando…
Management of hyperkalemia in chronic heart failure using sodium zirconium cyclosilicate
BACKGROUND: Sodium zirconium cyclosilicate (SZC), a newly‐developed selective potassium binder, has been clinically available to treat hyperkalemia. SZC might be a promising option to manage hyperkalemia, particularly in patients with heart failure, who often require potassium‐sparing medications. H...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wiley Periodicals, Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8427969/ https://www.ncbi.nlm.nih.gov/pubmed/34263946 http://dx.doi.org/10.1002/clc.23683 |